Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DIASORIN MOLECULAR, LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-10-01 to 2026-09-30
Current total value of award: $111720
Description: PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-22-P-0269 WITH DIASORIN MOLECULAR, LLC. IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2025 - 30 SEPTEMBER 2026 (OPTION PERIOD 3).